Oncostatin M, leukaemia-inhibitory factor and interleukin 6 trigger different effects on alpha1-proteinase inhibitor synthesis in human lung-derived epithelial cells

Biochem J. 1998 Jan 15;329 ( Pt 2)(Pt 2):335-9. doi: 10.1042/bj3290335.

Abstract

Interleukin 6 (IL-6), oncostatin M (OSM) and leukaemia-inhibitory factor (LIF) share a common signal-transducing subunit in each of their receptors and thus mediate an overlapping spectrum of biological activities. Although all of these cytokines stimulate the production of alpha1-proteinase inhibitor (alpha1-PI) in hepatocyte-derived cells, only OSM is able to up-regulate levels of this inhibitor in epithelial cells originating from the lung. In this study we characterized human lung-derived epithelial-like HTB58 cells for their ability to synthesize alpha1-PI after treatment with IL-6, OSM and LIF. The results demonstrate that the resistance of HTB58 cells to the effects of IL-6 and LIF was not because of a lack of their individual functional receptors and suggest that OSM utilizes two different receptors, gp130/LIF receptor and gp130/OSM receptor, in lung-derived epithelial cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Blotting, Northern
  • Blotting, Western
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Growth Inhibitors / pharmacology*
  • Humans
  • Interleukin-6 / pharmacology*
  • Leukemia Inhibitory Factor
  • Lung / cytology
  • Lung / drug effects*
  • Lung / metabolism
  • Lymphokines / pharmacology*
  • Oncostatin M
  • Peptides / pharmacology*
  • Tumor Cells, Cultured
  • alpha 1-Antitrypsin / biosynthesis*

Substances

  • Growth Inhibitors
  • Interleukin-6
  • LIF protein, human
  • Leukemia Inhibitory Factor
  • Lymphokines
  • OSM protein, human
  • Peptides
  • alpha 1-Antitrypsin
  • Oncostatin M